The Manila Times

MBX Biosciences Announces One-Year Data Demonstrating Sustained Benefit of Once-Weekly Canvuparatide as a Potential PTH Replacement Therapy in Chronic Hy…

Responder rate of 57% at one year in open-label extension (OLE) comparable to 63% at 12 weeks in Phase 2 Avail™ trial ...
YouTube on MSN

I learned database normalization the hard way

Learn database normalization through this tutorial that covers key concepts and processes of 1NF, 2NF, and 3NF. Discover ...
Morningstar

Actabl Earns U.S. Patent for Hotel Data Normalization as AI Raises the Stakes on Data Reliability

ATLANTA, May 13, 2026 /PRNewswire/ --Actabl, the leading hospitality software company dedicated to empowering hotels with actionable insights to drive profit, today announced it has been granted a U.S ...
The Manila Times

Cogent Biosciences Announces Detailed Data from APEX Pivotal Trial of Bezuclastinib in Patients with Advanced Systemic Mastocytosis at the 2026 European Hematology Association ...

Bezuclastinib demonstrated rapid and deep clinical benefit in AdvSM patients resulting in an updated objective response rate (CR+CRh+PR+CI) of 65% per mIWG criteria and 81% ORR per PPR criteria - ...